Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
79
days
Metabolic–epigenetic vulnerability in cardiometabolic HFpEF: One-carbon metabolism, DNMT maintenance, and methylation instability
Authors
Weichen Luo; Wenjie Zuo; Yang Xu; Mingming Yang; Zhenjun Ji; Genshan MaShow moreShow less
Affiliations
Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China; Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, ChinaShow moreShow less
80
days
Systematic screening identifies USP20 as an accelerator of metabolic dysfunction-associated steatotic liver disease via driving de novo lipogenesis
Authors
Xiaoxuan Ma; Weiwei Qin; Zian Feng; Nengneng Luan; Ruru Pan; Yanyan Diao; Zequn Yin; Suowen Xu; Junbo Ge; Shuang Zhang; Yajun DuanShow moreShow less
Affiliations
Department of Cardiology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China; Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, School of Pharmacy, Anhui Medical University, Hefei, China; Innovation Center for AI and Drug Discovery, School of Pharmacy, East China Normal University, Shanghai 200062, China; East China University of Science and Technology, Shanghai, China; Department of Endocrinology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, China; State Key Laboratory of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China; NHC Key Laboratory of Ischemic Heart Diseases, China; Key Laboratory of Viral Heart Diseases, Chinese Academy of Medical Sciences, China; National Clinical Research Center for Interventional Medicine, Shanghai, China; Institutes of Biomedical Sciences, Fudan University, Shanghai, China; College of Food and Biological Engineering, Hefei University of Technology, Hefei, ChinaShow moreShow less
105
days
Oncolytic virus-delivered CEACAM6/CD3 BiTEs combine with PD-1 blockade to achieve synergistic anticancer efficacy
Authors
Weiwei Zhang; Shuang Dai; Haohan Fan; Nian Yang; Long Xu; Zheran Liu; Yu Min; Zheng Jiang; Liangxue Zhou; Hui Yang; Aiping Tong; Xingchen PengShow moreShow less
Affiliations
Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, China; Department of Oncology, Cancer Prevention and Treatment Institute of Chengdu, Chengdu Fifth People’s Hospital (The Second Clinical Medical College, Affiliated Fifth People’s Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, Sichuan Province 610041, China; State Key Laboratory of Biotherapy and Cancer Center, Research Unit of Gene and Immunotherapy, Chinese Academy of Medical Sciences, Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, China; Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, China; Department of Neurosurgery, NHC Key Laboratory of Nuclear Technology Medical Transformation（Mianyang Central Hospital), School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan Province 621000, China; Department of Otolaryngology-Head & Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province 610041, China; Frontiers Medical Center, Tianfu Jincheng Laboratory, Chengdu, Sichuan Province 610212, China; Nuclear Physics and Medical Research Key Laboratory of Sichuan Province, Sichuan University, Chengdu, Sichuan Province 610041, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days